tebu-bio is pleased to announce their recent agreement with NanoSurface Biomedical

LE PERRAY-EN-YVELINES, France - July 4, 2016 - PRLog -- NanoSurface Biomedical and tebu-bio are pleased to announce their new sales and marketing agreement.

Under the terms of the agreement, tebu-bio will provide sales, marketing and application support of NanoSurface Biomedical's products to European Life Sciences researchers, through their local offices in Belgium, France, Germany, Italy, Netherlands, Denmark, Portugal, Spain, United Kingdom and Ireland. The agreement will thus expand NanoSurface Biomedical's global network.

Jean-François Têtu, Ph.D., Head of Cell Sourcing at tebu-bio said, "tebu-bio is excited to collaborate with NanoSurface Biomedical for the commercialization of their ANFS (Anisotropically NanoFabricated Substratum) technology. ANFS products enlarge tebu-bio's growing portfolio of solutions in the field of physiological cell culture. NanoSurface Biomedical's ANFS technology brings an in vivo-like cell culture platform to researchers for in vitro cell/tissue studies. Featuring topographical resemblance to the extracellular matrix, these nanopatterned substrates provide a topographical and mechanical niche for cells to grow as if they are in vivo. This is very promising for researchers working with mechanically sensitive cells."

Dr. Samuel Choi, Chief Technology Officer at NanoSurface Biomedical described NanoSurface's innovative cell culture technology as, "a powerful alternative to the conventional cell culture dish." He went on to say, "Unlike conventional dishes, which do nothing to mimic the mechanical characteristics of the native cellular microenvironment, NanoSurface dishes feature biomimetic nanotextured surface topography. To mechanically sensitive cells, parallel arrays of grooves and ridges on the nanoscale look and feel like the fibrous extra cellular matrix, which causes them to align and mature in the direction of the nanopattern. In conventional culture dishes, mechanically sensitive cells adopt random orientation and immature phenotypes. By contrast, cells cultured in NanoSurface dishes are structurally more physiologic, and phenotypically more mature." Elliot Fisher, Chief Operating Officer at NanoSurface Biomedical added, "Now available in single and multiwell formats, it has never been easier to try NanoSurface with many cell culture applications."

Jean-François Têtu added, "Our locally based specialists will be keen to introduce NanoSurface Biomedical's products to researchers with whom they are in contact day-to-day, and to guide them in choosing the products suited to their research projects."

About NanoSurface Biomedical

Align your cells. NanoSurface Biomedical (http://www.nanosurfacebio.com) offers next generation cell culture platforms featuring nanopatterned surfaces. These surfaces are biomimetic - their nanoscale grooves and ridges resemble the collagen fibers of native ECM. NanoSurface dishes cause cells to mature and elongate in the direction of the nanopattern, creating more mature and physiologic cell cultures than has ever been possible with conventional cultureware. NanoSurface is based in Seattle, WA, USA, where its dedicated researchers continue to develop advanced technologies at the interface of nanoscience and cell biology. Contact for NanoSurface Biomedical: Elliot Fisher (Chief Operating Officer) - elliot@nanosurfacebio.com.

About tebu-bio
tebu-bio (http://www.tebu-bio.com) is a pan-European company with 9 local offices throughout Europe, specialised in providing innovative reagents and laboratory services in Life Sciences. For more than ten years now, tebu-bio's own laboratories operating in France provide researchers with an ever-growing offer of standard or custom lab services. Contact for tebu-bio: Jean-François Têtu (Sales Manager - Cell Products) - jean.francois-tetu@tebu-bio.com.